NVAX:NASDAQ
Novavax Inc
$12.82
arrow_upward
+1.42%(+0.18) 1D
$12.88
arrow_upward
+0.47% (+0.060)bedtimePagkalipas ng oras ng trabaho
Sarado: Okt 15, 4:00:00 PM GMT-4 · USD
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa NVAX...
Buksan
$12.50
Mataas
$13.25
Mababa
$12.18
Mkt. cap
2.11B
Avg. na dami
7.42M
Dami
7.37M
Mataas nang 52-wk
$13.38
Mababa nang 52-wk
$6.20
EPS
-$1.52
Beta
2.44
Mga natitirang share
164.95M
Bilang ng mga empleyado
749
Buksan
$12.50
Mataas
$13.25
Mababa
$12.18
Mkt. cap
2.11B
Avg. na dami
7.42M
Dami
7.37M
Mataas nang 52-wk
$13.38
Mababa nang 52-wk
$6.20
EPS
-$1.52
Beta
2.44
Mga natitirang share
164.95M
Bilang ng mga empleyado
749
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
TradingView
·
4 oras ang nakalipas
Novavax, Inc. Stock 12‑Month Price Target Raised to $15, Implies 19% Upside
ad-hoc-news.de
·
8 oras ang nakalipas
BofA raises Novavax stock target from USD 7.00 to USD 8.00
GuruFocus
·
8 oras ang nakalipas
NVAX Maintained by Citigroup -- Price Target Raised to $8.00
Yahoo Finance
·
2 araw ang nakalipas
Novavax (NVAX) Increases Despite Market Slip: Here's What You Need to Know
Profile
Novavax, Inc., based in Gaithersburg, Maryland, develops vaccines to counter infectious diseases. The company developed the Novavax COVID-19 vaccine, now commercialized by Sanofi. The company also develops vaccines for influenza, respiratory syncytial virus, avian flu, shingles, Clostridioides difficile, and malaria.
Novavax develops proprietary immune-stimulating saponin-based immunologic adjuvants at a wholly owned Swedish subsidiary, Novavax AB. One of these, Matrix-M, is used in the Novavax COVID-19 vaccine. Wikipedia
Tungkol sa Novavax Inc
CEOJohn C. Jacobs
Mga Empleyado749
Itinatag1987
HeadquartersGaithersburg, Maryland, Estados Unidos
Sektor-
Websitenovavax.com